Carregant...
Fitxers
Tipus de document
ArticleVersió
Versió publicadaData de publicació
Llicència de publicació
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/176888
Growth Differentiation Factor 15 is a potential biomarker of therapeutic response for TK2 deficient myopathy
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
GDF-15 is a biomarker for mitochondrial diseases. We investigated the application of GDF-15 as biomarker of disease severity and response to deoxynucleoside treatment in patients with thymidine kinase 2 (TK2) deficiency and compared it to FGF-21. GDF-15 and FGF-21 were measured in serum from 24 patients with TK2 deficiency treated 1-49 months with oral deoxynucleosides. Patients were grouped according to age at treatment and biomarkers were analyzed at baseline and various time points after treatment initiation. GDF-15 was elevated on average 30-fold in children and 6-fold in adults before the start of treatment. There was a significant correlation between basal GDF-15 and severity based on pretreatment distance walked (6MWT) and weight (BMI). During treatment, GDF-15 significantly declined, and the decrease was accompanied by relevant clinical improvements. The decline was greater in the paediatric group, which included the most severe patients and showed the greatest clinical benefit, than in the adult patients. The decline of FGF-21 was less prominent and consistent. GDF-15 is a potential biomarker of severity and of therapeutic response for patients with TK2 deficiency. In addition, we show evidence of clinical benefit of deoxynucleoside treatment, especially when treatment is initiated at an early age.
Matèries
Matèries (anglès)
Citació
Citació
DOMÍNGUEZ GONZÁLEZ, Cristina, BADOSA, Carmen, MADRUGA GARRIDO, Marcos, MARTÍ, Itxaso, PARADAS, Carmen, ORTEZ, Carlos ignacio, DÍAZ MANERA, Jordi, BERARDO, Andrés, ALONSO PÉREZ, Jorge, TRIFUNOV, Selena, CUADRAS, Daniel, KALKO, Susana g., BLÁZQUEZ BERMEJO, Cora, CÁMARA NAVARRO, Yolanda, MARTÍ, Ramon, MAVILLARD, Fabiola, MARTÍN, Miguel a., MONTOYA, Julio, RUÍZ PESINI, Eduardo, VILLARROYA I TERRADE, Joan, MONTERO SÁNCHEZ, Raquel, VILLARROYA I GOMBAU, Francesc, ARTUCH IRIBERRI, Rafael, HIRANO, Michio, NASCIMENTO, Andrés, JIMÉNEZ MALLEBRERA, Cecilia. Growth Differentiation Factor 15 is a potential biomarker of therapeutic response for TK2 deficient myopathy. _Scientific Reports_. 2020. Vol. 10, núm. 1, pàgs. 10111. [consulta: 20 de gener de 2026]. ISSN: 2045-2322. [Disponible a: https://hdl.handle.net/2445/176888]